Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brett Hauber

Showing results (81-90 of 165) with videos related to

Pageof 17
Sort By:
British Journal of Clinical Pharmacology|March 12, 2022
Multimethod quantitative benefit-risk assessment of treatments for moderate-to-severe osteoarthritisJonathan Mauer, Kristin Bullok, Stephen Watt, et al.
The Patient|February 29, 2024
Using Patient Preferences in Health Technology Assessment: Evaluating Quality-Adjusted Survival Equivalents (QASE) for the Quantification of Non-health BenefitsKevin Marsh, Hannah Collacott, Jim Thomson, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|January 18, 2015
Physicians' preferences for bone metastases drug therapy in the United StatesJorge Arellano, A Brett Hauber, Ateesha F Mohamed, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|November 8, 2020
Patient perspectives regarding gene therapy in haemophilia: Interviews from the PAVING studyEline van Overbeeke, Sissel Michelsen, Brett Hauber, et al.
Journal of Health Economics and Outcomes Research|September 4, 2023
Japanese Patients' and Physicians' Preferences for Anticoagulant Use in Atrial Fibrillation: Results from a Discrete-choice ExperimentKen Okumura, Hiroshi Inoue, Masahiro Yasaka, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|October 8, 2016
A Framework for Incorporating Patient Preferences Regarding Benefits and Risks into Regulatory Assessment of Medical TechnologiesMartin Ho, Anindita Saha, K Kimberly McCleary, et al.
Journal of Medical Economics|July 20, 2012
Patients rank toxicity against progression free survival in second-line treatment of advanced renal cell carcinomaMichael K Wong, Ateesha F Mohamed, A Brett Hauber, et al.
BMC Medical Informatics and Decision Making|January 7, 2021
A revealed preference analysis to develop composite scores approximating lung allocation policy in the U.SDarren E Stewart, Dallas W Wood, James B Alcorn, et al.
BMC Infectious Diseases|April 19, 2024
Key informant views on potential acceptability and feasibility of long-acting antiretroviral treatment for HIV in KenyaAnne Kaggiah, Catherine N Maina, John Kinuthia, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|February 10, 2006
Stated preferences of patients with cancer for health-related quality-of-life (HRQOL) domains during treatmentDavid Osoba, Ming-Ann Hsu, Catherine Copley-Merriman, et al.
Pageof 17

Showing results (81-90 of 165) with videos related to

Sort By:
Pageof 17
British Journal of Clinical Pharmacology|March 12, 2022
Multimethod quantitative benefit-risk assessment of treatments for moderate-to-severe osteoarthritisJonathan Mauer, Kristin Bullok, Stephen Watt, et al.
The Patient|February 29, 2024
Using Patient Preferences in Health Technology Assessment: Evaluating Quality-Adjusted Survival Equivalents (QASE) for the Quantification of Non-health BenefitsKevin Marsh, Hannah Collacott, Jim Thomson, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|January 18, 2015
Physicians' preferences for bone metastases drug therapy in the United StatesJorge Arellano, A Brett Hauber, Ateesha F Mohamed, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|November 8, 2020
Patient perspectives regarding gene therapy in haemophilia: Interviews from the PAVING studyEline van Overbeeke, Sissel Michelsen, Brett Hauber, et al.
Journal of Health Economics and Outcomes Research|September 4, 2023
Japanese Patients' and Physicians' Preferences for Anticoagulant Use in Atrial Fibrillation: Results from a Discrete-choice ExperimentKen Okumura, Hiroshi Inoue, Masahiro Yasaka, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|October 8, 2016
A Framework for Incorporating Patient Preferences Regarding Benefits and Risks into Regulatory Assessment of Medical TechnologiesMartin Ho, Anindita Saha, K Kimberly McCleary, et al.
Journal of Medical Economics|July 20, 2012
Patients rank toxicity against progression free survival in second-line treatment of advanced renal cell carcinomaMichael K Wong, Ateesha F Mohamed, A Brett Hauber, et al.
BMC Medical Informatics and Decision Making|January 7, 2021
A revealed preference analysis to develop composite scores approximating lung allocation policy in the U.SDarren E Stewart, Dallas W Wood, James B Alcorn, et al.
BMC Infectious Diseases|April 19, 2024
Key informant views on potential acceptability and feasibility of long-acting antiretroviral treatment for HIV in KenyaAnne Kaggiah, Catherine N Maina, John Kinuthia, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|February 10, 2006
Stated preferences of patients with cancer for health-related quality-of-life (HRQOL) domains during treatmentDavid Osoba, Ming-Ann Hsu, Catherine Copley-Merriman, et al.
Pageof 17